Neurolupus
Main Article Content
Abstract
Downloads
Article Details
![Creative Commons License](http://i.creativecommons.org/l/by-nc/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
Jimйnez S, Cervera R, Font J, et al. The epidemiology of systemic lupus erythematosus. Clin Rev Allergy Immunol. 2003;25:3–12. DOI: https://doi.org/10.1385/CRIAI:25:1:3
Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725. DOI: https://doi.org/10.1002/art.1780400928
Hanly JG, McCurdy G, Fougere L, et al. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. Rheumatol. 2004;31:2156–62.
Hanly JG, Fisk JD, McCurdy G, et al. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol. 2005;32:1459–6.
Hanly JG, Su L, Farewell V, et al. Prospective study of neuropsychiatric events in systemic lupus erythematosus. J Rheumatol. 2009;36:1449–59. DOI: https://doi.org/10.3899/jrheum.081133
Ainiala H, Loukkola J, Peltola J, et al. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology. 2001;57:496–500. DOI: https://doi.org/10.1212/WNL.57.3.496
Scolding NJ, Joseph FG. The neuropathology and pathogenesis of systemic lupus erythematosus. Neuropathol Appl Neurobiol. 2002;28:173–89. DOI: https://doi.org/10.1046/j.1365-2990.2002.00406.x
Johnson RT, Richardson EP. The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore). 1968;47:337–69. DOI: https://doi.org/10.1097/00005792-196807000-00002
Ellis SG, Verity MA. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955–1977. Semin Arthritis Rheum. 1979;8:212–21. DOI: https://doi.org/10.1016/S0049-0172(79)80009-8
Devinsky O, Petito CK, Alonso DR. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol. 1988;23:380–4. DOI: https://doi.org/10.1002/ana.410230411
Hanly JG, Walsh NM, Sangalang V. Brain pathology in systemic lupus erythematosus. J Rheumatol. 1992;19:732–41.
Karassa FB, Afeltra A, Ambrozic A, et al. Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum. 2006;54:312–24. DOI: https://doi.org/10.1002/art.21539
Asherson RA, Cervera R, Merrill JT, et al. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment. Semin Thromb Hemost. 2008;34:256–66. DOI: https://doi.org/10.1055/s-0028-1082269
The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42:599–608. DOI: https://doi.org/10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F
Mitsikostas DD, Sfikakis PP, Goadsby PJ. A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth. Brain. 2004;127:1200–9. DOI: https://doi.org/10.1093/brain/awh146
Cimaz R, Meroni PL, Shoenfeld Y. Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome). Lupus. 2006;15:191–7. DOI: https://doi.org/10.1191/0961203306lu2272rr
Joseph FG, Lammie GA, Scolding NJ. CNS lupus: a study of 41 patients. Neurology. 2007;69:644–54. DOI: https://doi.org/10.1212/01.wnl.0000267320.48939.d0
Devreese K, Hoylaerts MF. Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome. Eur J Haematol. 2009;83:1–16. DOI: https://doi.org/10.1111/j.1600-0609.2009.01243.x
Wong RC, Favaloro EJ. Clinical features, diagnosis, and management of the antiphospholipid syndrome. Semin Thromb Hemost. 2008;34:295–304. DOI: https://doi.org/10.1055/s-0028-1082275
Bayraktar UD, Erkan D, Bucciarelli S, et al; Catastrophic Antiphospholipid Syndrome Project Group. The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus. J Rheumatol. 2007;34:346–52.
Scolding NJ, ed. Systemic inflammatory diseases and the nervous system. In: Contemporary treatments in neurology. Oxford: Butterworth Heinemann, 2001:187–215.
Stojanovich L, Zandman-Goddard G, Pavlovich S, et al. Psychiatric manifestations in systemic lupus erythematosus. Autoimmun Rev. 2007;6:421–6. DOI: https://doi.org/10.1016/j.autrev.2007.02.007
Pego-Reigosa JM, Isenberg DA. Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease. Rheumatology (Oxford). 2008;47:1498–502. DOI: https://doi.org/10.1093/rheumatology/ken260
Denburg SD, Carbotte RM, Denburg JA. Cognition and mood in systemic lupus erythematosus. Evaluation and pathogenesis. Ann N Y Acad Sci. 1997;823:44–59. DOI: https://doi.org/10.1111/j.1749-6632.1997.tb48378.x
Kovacs B, Lafferty TL, Brent LH, et al. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis. 2000;59:120–4. DOI: https://doi.org/10.1136/ard.59.2.120
Espinosa G, Mendizábal A, Mínguez S, Ramo-Tello C, Capellades J, Olivé A, Cervera R. Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: clinical, immunological, and radiological characteristics of 22 patients. Semin Arthritis Rheum. 2010;39(4):246-56. DOI: https://doi.org/10.1016/j.semarthrit.2008.09.002
Pittock SJ, Lennon VA, de Seze J, et al. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol. 2008;65:78–83. DOI: https://doi.org/10.1001/archneurol.2007.17
Fulford KW, Catterall RD, Delhanty JJ, et al. A collagen disorder of the nervous system presenting as multiple sclerosis. Brain. 1972;95:373–86. DOI: https://doi.org/10.1093/brain/95.2.373
Rosenbaum R. Neuromuscular complications of connective tissue diseases. Muscle Nerve. 2001;24:154–69. DOI: https://doi.org/10.1002/1097-4598(200102)24:2<154::AID-MUS20>3.0.CO;2-3
Vina ER, Fang AJ, Wallace DJ, et al. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome. Semin Arthritis Rheum. 2005;35:175–84. DOI: https://doi.org/10.1016/j.semarthrit.2005.08.008
Bhinder S, Majithia V, Harisdangkul V. Myasthenia gravis and systemic lupus erythematosus: truly associated or coincidental"”two case reports and review of the literature. Clin Rheumatol. 2006;25:555–6. DOI: https://doi.org/10.1007/s10067-005-0099-8
Cuchacovich R, Gedalia A. Pathophysiology and clinical spectrum of infections in systemic lupus erythematosus. Rheum Dis Clin North Am. 2009;35:75–93. DOI: https://doi.org/10.1016/j.rdc.2009.03.003
Karassa FB, Ioannidis JP, Touloumi G, et al. Risk factors for central nervous system involvement in systemic lupus erythematosus. QJM. 2000;93:169–74. DOI: https://doi.org/10.1093/qjmed/93.3.169
Creamer P, Kirwan J. Seronegative systemic lupus erythematosus. Br J Rheumatol. 1992;31:619–22. DOI: https://doi.org/10.1093/rheumatology/31.9.619
Craig WY, Ledue TB, Johnson AM, et al. The distribution of antinuclear antibody titers in "normal" children and adults. J Rheumatol. 1999;26:914–19.
Appenzeller S, Pike GB, Clarke AE. Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus. Clin Rev Allergy Immunol. 2008;34:361–6. DOI: https://doi.org/10.1007/s12016-007-8060-z
Graham JW, Jan W. MRI and the brain in systemic lupus erythematosus. Lupus. 2003;12:891–6. DOI: https://doi.org/10.1191/0961203303lu498oa
Peterson PL, Axford JS, Isenberg D. Imaging in CNS lupus. Best Pract Res Clin Rheumatol. 2005;19:727–39. DOI: https://doi.org/10.1016/j.berh.2005.04.001
Castellino G, Govoni M, Giacuzzo S, et al. Optimizing clinical monitoring of central nervous system involvement in SLE. Autoimmun Rev. 2008;7:297–304. DOI: https://doi.org/10.1016/j.autrev.2007.11.022
Guttman M, Lang AE, Garnett ES, et al. Regional cerebral glucose metabolism in SLE chorea: further evidence that striatal hypometabolism is not a correlate of chorea. Mov Disord. 1987;2:201–10. DOI: https://doi.org/10.1002/mds.870020307
Crowther MA, Ginsberg JS, Julian J, et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med. 2003;349:1133–8. DOI: https://doi.org/10.1056/NEJM200312253492627
Finazzi G, Marchioli R, Brancaccio V, et al. A randomized clinical trial of highintensity warfarin vs. Conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost. 2005;3:848–53. DOI: https://doi.org/10.1111/j.1538-7836.2005.01340.x
Lim W, Crowther MA, Eikelboom JW. Management of antiphospholipid antibody syndrome: a systematic review. JAMA. 2006;295:1050–7. DOI: https://doi.org/10.1001/jama.295.9.1050
Trevisani VF, Castro AA, Neves Neto JF, et al. Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus. Cochrane Database Syst Rev. 2006;19:CD002265. DOI: https://doi.org/10.1002/14651858.CD002265.pub2
Barile-Fabris L, Ariza-Andraca R, Olguнn-Ortega L, et al. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis. 2005;64:620–5. DOI: https://doi.org/10.1136/ard.2004.025528